Salarius Pharmaceuticals
SLRX
SLRX
12 hedge funds and large institutions have $697K invested in Salarius Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
less ownership
Funds ownership: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$121K | |
| 2 | +$57K | |
| 3 | +$20K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$13K |
Top Sellers
| 1 | -$165K | |
| 2 | -$44K | |
| 3 | -$30K | |
| 4 |
Primecap Management
Pasadena,
California
|
-$26K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$19.5K |